Peer review reports
From: No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone
Original Submission | ||
---|---|---|
25 Nov 2015 | Submitted | Original manuscript |
24 Dec 2015 | Reviewed | Reviewer Report - Shi Wei |
30 Dec 2015 | Reviewed | Reviewer Report - Ravi Singh |
29 Feb 2016 | Author responded | Author comments - Elisabeth Peterse |
Resubmission - Version 2 | ||
29 Feb 2016 | Submitted | Manuscript version 2 |
1 Jun 2016 | Author responded | Author comments - Elisabeth Peterse |
Resubmission - Version 3 | ||
1 Jun 2016 | Submitted | Manuscript version 3 |
24 Jun 2016 | Author responded | Author comments - Elisabeth Peterse |
Resubmission - Version 4 | ||
24 Jun 2016 | Submitted | Manuscript version 4 |
Publishing | ||
5 Jul 2016 | Editorially accepted | |
14 Jul 2016 | Article published | 10.1186/s12885-016-2522-8 |